The company's BV Flex test measures patient immune proteins in capillary blood samples to determine whether an individual has a bacterial or viral infection.
MeMed Severity™ has received FDA Breakthrough Device Designation as a host-response test designed to predict severe outcomes up to 72 hours and mortality 14 days in advance in patients with acute ...
The Midland County Department of Public Health (MCDPH) offers appointments for capillary blood lead testing (finger poke) to identify lead exposure in children. As of April 30, the Michigan universal ...